By virtue of its two university hospitals in Lausanne and Geneva, the SCCL community lends itself to a highly effective transfer of knowledge and know-how, from bench to bedside.
Sixty specialist medical oncologists, radiologists, hematologists and immuno-oncologists, 120 junior or mid-career doctors and numerous structures and processes allow for clinical-translational optimisation, to fully develop and propose solutions for patients.
Centers of Excellence, developed in both hospitals, provide leadership, best practices, research, supportive care, education and training linked to specific tumour types. Each center unites all the skill-sets necessary to take on the care of patients diagnosed with a malignant disease, within a patient-centered structure. This approach secures the coordination of care, from the diagnosis to post-treatment follow-up, in accordance with best practice recommendations of each specialization (EBP-Evidence Based Practice), creating as many fast-track clinical pathways and onestop-shop opportunities to care. The goals of the SCCL centers of excellence are to:
- assure the quality of care and guarantee interdisciplinary team work
- offer a comprehensive treatment plan to patients
- develop innovation through clinical and translational research
- ensure the development of skills
The creation of a Center for experimental therapeutics (CTE), on the Lausanne University Hospital campus, working at the interface of basic and clinical research across both university hospitals, provides an integrated platform to support clinical innovation and patient-oriented translational research.
Internationally recognised phase I/II clinical research units for oncology within both university hospitals allow the SCCL to develop academic and industrial cell therapies.
A joint web platform, listing all clinical trials open in Lausanne and Geneva, offers external practitioners a compendium of all currently available innovative treatments.
A weekly Molecular tumour board (MTB), video-conferenced and co-hosted by both hospitals, brings together specialists from the academic and the private sector to analyse patient files submitted for review and to discuss their potential access to available innovative therapies.